A study performed in acute lymphoblastic leukemia cell lines showed that the inhibition of the AKT pathway synergizes with the MDM2 inhibitor Nutlin-3 to induce p53 reactivation and, consequently, cancer cells apoptosis (Zhu et al., 2008). This evidence concerns the gene TP53 and cancer.